These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 9288572

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation.
    Reiter RJ.
    Front Neuroendocrinol; 1995 Oct; 16(4):383-415. PubMed ID: 8557171
    [Abstract] [Full Text] [Related]

  • 3. Suppression of oxygen toxicity by melatonin.
    Reiter RJ, Tan DX, Qi WB.
    Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):575-81. PubMed ID: 10437151
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological actions of melatonin in oxygen radical pathophysiology.
    Reiter R, Tang L, Garcia JJ, Muñoz-Hoyos A.
    Life Sci; 1997 Nov; 60(25):2255-71. PubMed ID: 9194681
    [Abstract] [Full Text] [Related]

  • 5. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system.
    Reiter RJ, Acuña-Castroviejo D, Tan DX, Burkhardt S.
    Ann N Y Acad Sci; 2001 Jun; 939():200-15. PubMed ID: 11462772
    [Abstract] [Full Text] [Related]

  • 6. [Free oxygen radiacals and kidney diseases--part I].
    Sakac V, Sakac M.
    Med Pregl; 2000 Jun; 53(9-10):463-74. PubMed ID: 11320727
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective role of melatonin in oxidative stress vulnerable brain.
    Gupta YK, Gupta M, Kohli K.
    Indian J Physiol Pharmacol; 2003 Oct; 47(4):373-86. PubMed ID: 15266948
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage.
    Reiter RJ, Tan DX, Gitto E, Sainz RM, Mayo JC, Leon J, Manchester LC, Vijayalaxmi, Kilic E, Kilic U.
    Pol J Pharmacol; 2004 Oct; 56(2):159-70. PubMed ID: 15156066
    [Abstract] [Full Text] [Related]

  • 9. Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.
    Reiter RJ, Tan DX, Allegra M.
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():3-8. PubMed ID: 12019343
    [Abstract] [Full Text] [Related]

  • 10. Reactive oxygen intermediates, molecular damage, and aging. Relation to melatonin.
    Reiter RJ, Guerrero JM, Garcia JJ, Acuña-Castroviejo D.
    Ann N Y Acad Sci; 1998 Nov 20; 854():410-24. PubMed ID: 9928448
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A review of the evidence supporting melatonin's role as an antioxidant.
    Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, Ortiz GG, Acuña-Castroviejo D.
    J Pineal Res; 1995 Jan 20; 18(1):1-11. PubMed ID: 7776173
    [Abstract] [Full Text] [Related]

  • 13. Melatonin oxidative stress and neurodegenerative diseases.
    Srinivasan V.
    Indian J Exp Biol; 2002 Jun 20; 40(6):668-79. PubMed ID: 12587715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage.
    Reiter RJ, Tan DX, Manchester LC, Tamura H.
    J Physiol Pharmacol; 2007 Dec 20; 58 Suppl 6():5-22. PubMed ID: 18212398
    [Abstract] [Full Text] [Related]

  • 16. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites.
    Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD.
    Neuro Endocrinol Lett; 2008 Aug 20; 29(4):391-8. PubMed ID: 18766165
    [Abstract] [Full Text] [Related]

  • 17. [Free radicals and antioxidants: human physiology, pathology and therapeutic aspects].
    Sahnoun Z, Jamoussi K, Zeghal KM.
    Therapie; 1997 Aug 20; 52(4):251-70. PubMed ID: 9437876
    [Abstract] [Full Text] [Related]

  • 18. Oxidative toxicity in models of neurodegeneration: responses to melatonin.
    Reiter RJ, Garcia JJ, Pie J.
    Restor Neurol Neurosci; 1998 Jun 20; 12(2-3):135-42. PubMed ID: 12671308
    [Abstract] [Full Text] [Related]

  • 19. Interactions of the pineal hormone melatonin with oxygen-centered free radicals: a brief review.
    Reiter RJ.
    Braz J Med Biol Res; 1993 Nov 20; 26(11):1141-55. PubMed ID: 8136717
    [Abstract] [Full Text] [Related]

  • 20. Oxidative processes and antioxidative defense mechanisms in the aging brain.
    Reiter RJ.
    FASEB J; 1995 Apr 20; 9(7):526-33. PubMed ID: 7737461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.